{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:40:19Z","timestamp":1780555219595,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Xinjiang Uygur Autonomous Region","award":["No. 2017D01C396"],"award-info":[{"award-number":["No. 2017D01C396"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The present study is to analyze the difference of gene methylation in early cervical adenocarcinoma and to find molecular markers for predicting the occurrence and development of cervical adenocarcinoma.<\/jats:p>\n                    <jats:p>A total of 15 cases of primary cervical adenocarcinoma and 10 cases of primary cervical squamous cell carcinoma at stages IB1 or IIA1 were included in the study. Infinium MethylationEPIC BeadChip (850K) was used to screen specifically expressed genes in cervical adenocarcinoma tissues. Bisulfite sequencing polymerase chain reaction (BSP) and quantitative real-time polymerase chain reaction (qRT-PCR) were used to verify the methylation levels in cervical adenocarcinoma, cervical squamous cell carcinoma, and normal cervical tissues.<\/jats:p>\n                    <jats:p>Sex determining region Y-box 1 (SOX1) and cyclin D1 (CCND1) genes participated in multiple signaling pathways, being the central nodes of gene regulatory networks. SOX1 gene, but not CCND1 gene, was a specifically methylated gene in cervical adenocarcinoma according to BSP. According to qRT-PCR, methylation level of SOX1 in cervical adenocarcinoma tissues is significantly different from that in cervical squamous cell carcinoma tissues or normal cervical tissues, and the methylation level of CCND1 in cervical adenocarcinoma tissues or cervical squamous cell carcinoma tissues is significantly different from that in normal cervical tissues.<\/jats:p>\n                    <jats:p>The present study demonstrates that tumor-suppressor gene SOX1 is a methylation-specific expression gene of cervical adenocarcinoma and is expected to become a specific molecular marker for the diagnosis of cervical adenocarcinoma. However, CCND1 gene was not proven to be a specific methylation expression gene in cervical adenocarcinoma in the present study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000017225","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T23:53:37Z","timestamp":1569887617000},"page":"e17225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma"],"prefix":"10.1097","volume":"98","author":[{"given":"Min","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzhalinuer","family":"Abulizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jnci.2013.01.005","article-title":"ProExC is a novel marker for distinguishing between primary endometrial and endocervical adenocarcinomas","volume":"25","author":"Esheba","year":"2013","journal-title":"J Egypt Natl Cancer Inst"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"e55975","DOI":"10.1371\/journal.pone.0055975","article-title":"Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer","volume":"8","author":"Espinosa","year":"2013","journal-title":"PloS One"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/path.2930","article-title":"Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer","volume":"225","author":"Moelans","year":"2011","journal-title":"J Pathol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2010.07.028","article-title":"Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy","volume":"119","author":"Lim","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"(suppl 1)","key":"R7-20260519","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1386-6532(09)70004-6","article-title":"Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology","volume":"45","author":"Huang","year":"2009","journal-title":"J Clin Virol"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2018.06.014","article-title":"Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer","volume":"150","author":"Rogeri","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.4161\/epi.22301","article-title":"Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia","volume":"7","author":"Lendvai","year":"2012","journal-title":"Epigenetics"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13402-011-0056-2","article-title":"Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis","volume":"34","author":"Sobti","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4161\/epi.26346","article-title":"Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer","volume":"8","author":"Farkas","year":"2013","journal-title":"Epigenetics"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajog.2010.07.036","article-title":"Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results","volume":"204","author":"Lin","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jgh.12078","article-title":"Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma","volume":"28","author":"Shih","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.oraloncology.2018.06.007","article-title":"Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"83","author":"Ramos-Garcia","year":"2018","journal-title":"Oral oncology"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1567202615666180813130143","article-title":"MicroRNA-490-5P targets CCND1 to suppress cellular proliferation in glioma cells and tissue through cell cycle arrest","volume":"15","author":"Zhao","year":"2018","journal-title":"Curr Neurovasc Res"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/cbt.72","article-title":"Cycling to cancer with cyclin D1","volume":"1","author":"Diehl","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0300891617753477","article-title":"Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients","volume":"104","author":"Pandey","year":"2018","journal-title":"Tumori"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:00:54Z","timestamp":1779206454000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017225","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"2019-01-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}